Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MANÜ Telehealth vs Rivas Medical Weight Loss

MANÜ Telehealth
Graded #83

Higher grade

vs+16.6
Rivas Medical Weight Loss
Graded #437

Lower grade

The verdict

MANÜ Telehealth takes it — 72.2/100 to 55.6/100.

MANÜ Telehealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMANÜ Telehealth +40
85
45
Dose & formulationMANÜ Telehealth +24
64
40
Clinical oversightRivas Medical Weight Loss +2
79
81
Labs & monitoringMANÜ Telehealth +10
63
53
FulfillmentMANÜ Telehealth +6
71
65
Contract termsEven
55
55
MANÜ Telehealth · left barRivas Medical Weight Loss · right bar

The numbers

MetricMANÜ TelehealthRivas Medical Weight Loss
WeighScore72.2/10055.6/100
GradeCC
Scorecard rank#83#437
Semaglutide$120/mo (compounded)Not disclosed
Tirzepatide$150/mo (compounded)Not disclosed
CoverageCoverage not published3 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
MANÜ Telehealth

Graded #83 · C

Strengths

  • Compounded GLP-1s advertised from about $4-$5/day
  • 100% online with free discreet shipping and no insurance needed
  • Compounds exclusively from US 503A pharmacies
  • Add-on options like MIC Ultraburn and NAD+

Where it loses points

  • Per-dose pricing is gated behind login/signup, not public
  • State availability changes and is only confirmed at signup
  • Compounded medications are not FDA-evaluated

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard